Fosphenytoin Sodium Injection
Product Images NDC 0641-6136

7 FDA label images from Hikma Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Fosphenytoin Sodium (NDC 0641-6136). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Fosphenytoin Sodium Injection Usp 1)

Structure (Fosphenytoin Sodium Injection Usp 1)
Chemical structure of Fosphenytoin Sodium showing its molecular components including a phenytoin moiety linked to a phosphate group with two sodium ions indicated.*
FDA Label Image

Graph (Fosphenytoin Sodium Injection Usp 2)

Graph (Fosphenytoin Sodium Injection Usp 2)
A pharmacokinetic curve chart showing plasma unbound phenytoin concentration (µg/mL) over time (hours) after start of infusion. The main graph covers 0 to 2 hours, with multiple plotted data series represented by different symbols. An inset graph displays an extended timeline from 0 to 96 hours, also showing plasma unbound phenytoin concentration changes after start of infusion.*
FDA Label Image

462-439-02 (Fosphenytoin Sodium Injection Usp 3)

462-439-02 (Fosphenytoin Sodium Injection Usp 3)
Fosphenytoin Sodium Injection, USP label showing 100 mg PE per 2 mL (50 mg PE/mL) dosage strength. The injection is for intramuscular (IM) or intravenous (IV) use, with a 2 mL vial volume. The product is manufactured by Hikma Pharmaceuticals USA Inc. The label includes the NDC 0641-6136-01 with barcodes and placeholders for lot and expiration information.*
FDA Label Image

462-440-04 (Fosphenytoin Sodium Injection Usp 4)

462-440-04 (Fosphenytoin Sodium Injection Usp 4)
Fosphenytoin Sodium Injection, USP, 100 mg PE per 2 mL (50 mg PE/mL) by Hikma Pharmaceuticals USA Inc. The label indicates this is a single-dose vial for intramuscular or intravenous use. It includes storage instructions, dosage equivalence, and manufacturer details in Berkeley Heights, NJ.*
FDA Label Image

10 mL Vial (Fosphenytoin Sodium Injection Usp 5)

10 mL Vial (Fosphenytoin Sodium Injection Usp 5)
Fosphenytoin Sodium Injection, USP 500 mg PE per 10 mL (50 mg PE/mL) vial label. The product is for intramuscular (IM) or intravenous (IV) use, supplied in a 10 mL vial. Labeler is Hikma Pharmaceuticals USA Inc. The label includes dosage strength, route, and storage instructions.*
FDA Label Image

462-482-03 (Fosphenytoin Sodium Injection Usp 6)

462-482-03 (Fosphenytoin Sodium Injection Usp 6)
Label for Fosphenytoin Sodium Injection, USP 500 mg PE per 10 mL (50 mg PE/mL) by Hikma Pharmaceuticals USA Inc. The label indicates the product is for intramuscular and intravenous use, presented in 10 single-dose 10 mL vials. Additional information includes storage instructions (2°C to 8°C), note about usage, and barcode with lot and expiry placeholders.*
FDA Label Image

Fosphenytoin Sodium Injection Usp 7

Fosphenytoin Sodium Injection Usp 7
Fosphenytoin Sodium 50 mg/mL injection label showing a QR code and printed tracking data fields including GTIN, serial number, expiration date, and lot number. Label is for intramuscular and intravenous administration by Hikma Pharmaceuticals USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.